Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.30 Analyst target: $15.00 Upside: 138.10%
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.